The lion's share of this book describes the ways in which he confronted GlaxoSmithKline and the UK's drug regulatory agency. He used his blog to detail everything about Seroxat including how it came to market, the dangers that were routinely covered up or dismissed, and how it affected the lives of so many others. The blog gains the company's attention more than few times, and the way all of that plays out makes for interesting reading. I, personally, loved Bob's pain-in-the-ass approach, which would have made the book comical had the subject been anything remotely funny.
A big takeaway for me came from a section in the book where he clearly illustrates how responsibility for drug safety information shifts depending on which part of the system you talk to. A drug company might say, “talk to your doctor,” while your doctor will say, “the drug company would know,” on and on ad nauseam.
I would recommend this book to anyone seeking a deeper understanding of just how drug companies, healthcare systems, and regulatory agencies work synergistically to end up delivering dangerous treatments to unsuspecting patients.
To learn more about Bob you can visit his blog at: http://fiddaman.blogspot.com/